EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
17/03/2025
Voltar para busca
Dado oficial do USPTO
INFLAMMATION AT INTERFACES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
55
Atualização mais recente
21/03/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 41, 42, 44
Data de depósito
22/02/2010
Data de registro
07/06/2011
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/10/2021
Última transação
21/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
Kiel, DE
Examinador
NADELMAN, ANDREA
Unidade examinadora
M10
Descrição da marca
The mark consists of three crescent-shaped curved lines, with the top crescent in blue, the bottom right crescent in red and the bottom left crescent in gray. Beneath the three crescents is the wording "Inflammation at Interfaces" in gray
Titulares e representantes
Titulares
C. K. (pessoa física)
Christian-Albrechts-; Universität zu Kiel
Representantes
Syed Abedi Seed IP Law Group LLP
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
[ Business management and administration, operation of business for others, namely, medical care and research organizations, in particular in the field of inflammation medicine; organization and arrangement of trade exhibitions and trade fairs for scientific businesses, commercial and advertising purposes; business marketing services and public relations; distribution of advertising material; procurement of service contracts for others, namely, procuring of labor contracting services for others ]
Classe 41
Education and training, in particular arranging and conducting of seminars and workshops and academic enrichment programs in the field of inflammation medicine for young academics
Classe 42
Scientific services and research activities, in particular scientific research for medical purposes, namely providing medical research, clinical research and interdisciplinary medical research in the field of inflammation medicine, including fundamental research, contract research and clinical trials; pharmaceutical drug development services and conducting clinical trials featuring the application of new therapies and therapy approaches and diagnostic methods for scientific purposes; scientific study and research in the field of inflammation medicine featuring reports and surveys; industrial analysis, namely, conducting technical project studies in the field of high-throughput of molecular diagnostics, and translational and clinical research based on molecular makeup of patients
Classe 44
[ Medical services, in particular medical and clinical analysis in the nature of medical analysis of inflammation medicine and inflammation related conditions; therapeutic and medical treatment and attendance, namely, providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns, and including analysis of patient's environment, analysis of life circumstances, genetically disposition analysis, and hereditary family analysis; services of a hospital; medical care, namely, medical care for inflammation related conditions ]
Publicações
Histórico de despachos e eventos da marca no USPTO.
55 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/03/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
17/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/03/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
25/09/2022
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
23/08/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
23/08/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
25/06/2022
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
25/10/2021
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
25/10/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25/10/2021
ES71
TEAS SECTION 71 RECEIVED
20/05/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/12/2020
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/06/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
16/04/2020
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
01/12/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
16/11/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
04/05/2018
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
15/03/2018
XXCR
GENERIC MADRID TRANSACTION CREATED
15/03/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/03/2018
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
05/07/2017
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
05/07/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/07/2017
ES75
TEAS SECTION 71 & 15 RECEIVED
06/06/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/02/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/10/2011
FIMP
FINAL DISPOSITION PROCESSED
27/10/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/09/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
07/06/2011
PUBO
PUBLISHED FOR OPPOSITION
22/03/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/03/2011
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2011
NPUB
NOTICE OF PUBLICATION
02/03/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
16/02/2011
ALIE
ASSIGNED TO LIE
11/02/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/01/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/01/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/01/2011
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/01/2011
CNFR
FINAL REFUSAL MAILED
03/12/2010
CNFR
FINAL REFUSAL WRITTEN
02/12/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/11/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/11/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/11/2010
RFNT
REFUSAL PROCESSED BY IB
02/07/2010
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/06/2010
RFRR
REFUSAL PROCESSED BY MPU
03/06/2010
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/06/2010
CNRT
NON-FINAL ACTION WRITTEN
02/06/2010
DOCK
ASSIGNED TO EXAMINER
26/05/2010
MAFR
APPLICATION FILING RECEIPT MAILED
20/04/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/04/2010
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/04/2010
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INFLAMMATION AT INTERFACES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.